Pharmafile Logo

global access

- PMLiVE

Lundbeck promotes Andreas Eggert and Klaus Abel to senior commercial roles

Will oversee launch of new medicines and Otsuka partnership respectively

- PMLiVE

COPD-asthma market to reach $47bn in 2017

Aging population, increased pollution and new drugs will lead to growth, says report

- PMLiVE

Driving early clinical and commercial alignment

Real-world studies can provide evidence to ensure that your brand resonates with your customers

Health economics teams are making significant use of patient reported outcomes

The measures impact reimbursement and also aid payer communication

Pfizer launches Latin American vaccine education campaign

Public-facing pneumococcal disease campaign will cover 14 countries in the region

Allergan signs $1.4bn eye drug deal with Molecular Partners

Will develop DARPin proteins to target AMD and other eye conditions

- PMLiVE

US mobile health app prescribing pilot begins

Will focus on six areas, including cardiology, rheumatology and endocrinology health apps

- PMLiVE

FDA delays review deadline for Pfizer arthritis drug

Follows addition of new submission data for tofacitinib

Sanofi pulls Campath in EU and US

Withdraws cancer drug to avoid its off-label use in MS

- PMLiVE

Manish Singh resigns as CEO of ImmunoCellular Therapeutics

Replaced on interim basis by company chair and chief scientific officer Dr John Yu

- PMLiVE

Dr Alexander Milstein joins Belgium biotech Cardio3 BioSciences

Takes up role as vice president of clinical development

Pharma deals during July 2012

In this regular review of deals we focus on transactions announced during July 2012

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links